SAD/MAD Services & Products

  1. Early-Phase Metabolic Development
    2/12/2012
    ICON’s consultancy services advise on clinical pharmacology study designs based on preclinical data – including potential use of surrogate markers and pharmacodynamic models, validation of those markers and models, clear objective setting and flexible protocol design.
  2. First In Human Clinical Trials
    6/23/2011
    Timely and accurate data regarding the safety and efficacy of drug is critical for success at every stage of drug discovery and development.